Recent Police Force News:
Related Videos:
Palomar - "Never Grieve" @ Bruar Falls in Brooklyn 8-22-09
This is a new song that will be coming out on Palomar's album, Sense & Antisense. Look for it on Misra Records misrarecords.com palomartheband.com myspace.com Rachel Warren - vocals, guitar Christina Prostano - keyboards, vocals Sarah Brockett - bass, vocals Dale W. Miller - drums Recorded live at Bruar Falls in Brooklyn , NY 8-22-09 w/My Teenage Stride, Folklore & Knight School
Palomar - "Wouldn't Release You" @ Bruar Falls in Brooklyn 8-22-09
This is a new song that will be coming out on Palomar's yet untitled album. Look for it on Misra Records misrarecords.com palomartheband.com myspace.com Rachel Warren - vocals, guitar Christina Prostano - keyboards, vocals Sarah Brockett - bass Dale W. Miller - drums Recorded live at Bruar Falls in Brooklyn , NY 8-22-09 w/My Teenage Stride, Folklore & Knight School
Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligon
NittoPhase™ HL Loaded up to 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields
Global Dyslipidemia Therapeutics Market to Exceed $28 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of global report on Dyslipidemia Therapeutics market. The world market for Dyslipidemia Therapeutics is projected to exceed $28 billion by the year 2015. One of the key factors propelling the growth of anti-dyslipidemic drug market is aging population and the rising population of hypercholesterolemia patients.
Leaders from Drug Delivery Industry to Discuss Advances in Biotech, Nanotech and Targeted Delivery Technologies at Arrowhead's 3rd Annual Drug D
Arrowhead's 3rd Annual Drug Delivery Summit, scheduled to take place in San Francisco, CA on May 14th and May 15th, 2009, will be bringing together leaders from the drug delivery industry to discuss the newest and most important advances being made in the field of drug delivery.
Ryogen is Awarded Patents on Two Human Genes
Ryogen LLC is awarded two U.S. Patent Nos. 7,468,266, titled "Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2," and 7,470,522 , titled "Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2.
Arrowhead Publishers Releases New Report Analyzing the Global Cancer Therapy Market
A New report from Arrowhead Publishers entitled Cancer Therapeutics: Market Insight and R&D Pipeline Analysis provides valuable insight into the global market for cancer therapies and developmental-stage therapies.
Nanomedicine Company Nanobiotix Elects Former Sanofi-Aventis Oncology Researcher Elsa Borghi, MD, as its Medical Director : Podcast available at www
Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that it has appointed Elsa Borghi, MD, as medical director.
Global Prostate Cancer Therapeutics Market to Reach $4.8 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
Development of new therapies and drugs for prostate cancer is likely to supplement, rather substitute the prevailing drugs or therapies, such as chemotherapy, radiation therapy, hormonal therapy and surgery, and propel sales in global prostate cancer therapeutics market to $4.8 billion by 2015.
Scientific and Business Leaders to Discuss Challenges Facing Developers of Pain Therapeutics at Arrowhead’s 4th Annual Pain Therapeutics Summit
Now in its 4th year, Arrowhead's Annual Pain Therapeutics Summit continues to attract both academic and industry leaders from around the globe to discuss pain management, preclinical and clinical development of new pain therapeutics.
cordblood.asia
antisensedrugs.com
The antisense drug resource
adultstemcell.org
The adult stem cell forum
bionews.org
drugengineering.com
